102 papers
Understanding the human mind and treating mental health conditions requires a deep blend of biological insight and behavioral science. This category explores the cutting-edge research shaping how we diagnose and treat psychiatric disorders, from depression and anxiety to complex neurological conditions. Here, you will find the latest discoveries that bridge the gap between clinical observation and molecular mechanisms, offering fresh perspectives on patient care and therapeutic innovation.
Gist.Science brings these vital studies directly to you by monitoring medRxiv, the leading preprint server for health sciences. As soon as new manuscripts appear in this field, our team processes them to provide both accessible plain-language summaries and detailed technical overviews. This ensures that complex findings are understandable for everyone, from curious readers to busy professionals who need quick, accurate insights without wading through dense academic prose.
Below are the most recent psychiatry and clinical psychology preprints, curated and summarized to keep you informed on the evolving landscape of mental health research.
This study identifies decreasing intra-hippocampal connectivity as a specific, prognostic neural marker that precedes and predicts the worsening of negative symptoms and functional decline in individuals at clinical high risk for psychosis.
Using a system dynamics model calibrated to national survey data, this study reveals that while depression prevalence in South Africa has remained relatively stable from 2002 to 2024, antidepressant use remains low overall with a stark disparity between the private and public health sectors.
Using UK Biobank data, this study reveals that individuals with bipolar disorder who have an evening chronotype exhibit significantly larger volumes in the circadian-regulating anterior-inferior hypothalamic region compared to their morning chronotype counterparts, a structural difference not observed in other psychiatric diagnoses or hypothalamic subunits.
A survey of 55 individuals at clinical high risk for psychosis found that cannabidiol (CBD) is a highly acceptable treatment option, with most participants familiar with the compound, willing to use it, and anticipating fewer side effects compared to existing medications.
This randomized crossover study demonstrates that while naltrexone does not block ketamine-induced increases in regional cerebral blood flow in major depressive disorder, it disrupts the associations between these hemodynamic changes and both subjective effects and antidepressant response, suggesting that opioidergic modulation interacts with glutamatergic and GABAergic systems to influence ketamine's therapeutic mechanisms.
This study demonstrates that in-scanner head motion is a significant confounding factor in structural MRI analyses of schizophrenia, accounting for a substantial portion of observed grey matter differences between patients and controls and suggesting that many reported morphometric findings may be motion-driven artifacts rather than true tissue properties.
This study utilizes a unique multimodal dataset to demonstrate that while affective and functional disturbances emerge in early psychosis stages, cognitive and neuroanatomical abnormalities characterize more advanced phases, yet significant overlapping phenotypes across risk groups underscore the need for personalized care beyond traditional diagnostic boundaries.
This randomized controlled trial demonstrates that long-term use of the video game therapeutic Meliora for major depressive disorder does not increase gaming-related problems, even with high engagement or immersion, supporting the safety of video games as a medium for digital therapeutics.
This paper presents a protocol and literature review for the "Impact Log," a novel, lived-experience-led tool and framework designed to systematically record, evaluate, and enhance the impact of co-production across all stages of the Brain and Genomics Hub's multidisciplinary research on severe mental illness.
This systematic review and meta-analysis of 68 studies involving over 82,000 participants reveals that posttraumatic stress disorder affects approximately 43% of conflict-affected adults in Sub-Saharan Africa, with significantly higher rates among refugees and strong associations with female sex, comorbid depression, and cumulative trauma exposure.